Wecare Probiotics Co., Ltd.

Proud of our team as 𝘞𝘦𝘪𝘻𝘮𝘢𝘯𝘯𝘪𝘢 (𝘉𝘢𝘤𝘪𝘭𝘭𝘶𝘴) 𝘤𝘰𝘢𝘨𝘶𝘭𝘢𝘯𝘴 𝐁𝐂𝟗𝟗 successfully passes review by 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐆𝐨𝐨𝐝𝐬 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 (𝐓𝐆𝐀), becoming the first probiotic strain developed in China permitted for use in Australian listed medicines. Behind this milestone is years of commitment to strain research, clinical evidence and quality. My thanks to everyone who helped bring BC99 from scientific discovery to this important step in international market access. I look forward to working with our partners to explore new possibilities for BC99 in sports nutrition and beyond. #AustraliaRegulatory #PharmaCompliance #TGAregistration #probiotics #SportsNutrition

𝐓𝐆𝐀 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭: 𝐁𝐂𝟗𝟗, 𝐚 𝐏𝐫𝐨𝐛𝐢𝐨𝐭𝐢𝐜 𝐟𝐨𝐫 𝐒𝐩𝐨𝐫𝐭𝐬 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧, 𝐀𝐩𝐩𝐫𝐨𝐯𝐞𝐝 𝐟𝐨𝐫 𝐔𝐬𝐞 𝐢𝐧 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚𝐧 𝐋𝐢𝐬𝐭𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 🇦🇺🌏 Our proprietary strain, 𝘞𝘦𝘪𝘻𝘮𝘢𝘯𝘯𝘪𝘢 (𝘉𝘢𝘤𝘪𝘭𝘭𝘶𝘴) 𝘤𝘰𝘢𝘨𝘶𝘭𝘢𝘯𝘴 𝐁𝐂𝟗𝟗, has successfully passed review by 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐆𝐨𝐨𝐝𝐬 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 (𝐓𝐆𝐀), becoming the first probiotic strain developed in China permitted for use in Australian listed medicines. This milestone marks recognition of BC99’s safety, stability and quality control systems by an internationally respected regulatory authority. It further strengthens BC99’s position as a benchmark in functional probiotics and represents a major breakthrough in Wecare’s global strain commercialisation strategy. Backed by extensive human clinical research, proprietary intellectual property and established manufacturing capabilities, BC99 brings together scientific depth and commercial strength to support probiotic innovation. From proprietary strain research to international market access, Wecare continues to bring original probiotic science from China to the world through high-quality ingredients and one-stop CRDMO solutions.💪 #SportsNutrition #probiotics #GutHealth #AustraliaRegulatory #PharmaCompliance #TGAregistration

🏌️Swing by Lobby B. Tee off with Wecare! Heading to SupplySide Global 2026? Take a break from the show floor and enjoy a round of virtual golf, sponsored by Wecare Probiotics. Whether you’re a seasoned golfer or picking up a club for the first time, stop by, take a swing, and connect with fellow attendees. A great conversation could be just a swing away! 📍 Lobby B | Booth #7806 📅 October 28–30, 2026 📌 Las Vegas, USA See you at SupplySide Global! ⛳ #SupplySideGlobal #probiotics #microbiome #Golf

A recent review in Nature Reviews Microbiology examines how bifidobacteria adapt to their hosts, contribute to gut ecology and relate to human health. Jointly authored by teams led by Marco Ventura at the University of Parma and Douwe van Sinderen at APC Microbiome Ireland, it offers valuable insights for early-life microbiome research. This aligns closely with our work on𝘉𝘪𝘧𝘪𝘥𝘰𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘶𝘮 𝘢𝘯𝘪𝘮𝘢𝘭𝘪𝘴 𝘴𝘶𝘣𝘴𝘱. 𝘭𝘢𝘤𝘵𝘪𝘴 𝐁𝐋𝐚𝟖𝟎, one of Wecare’s core proprietary strains. Through strain identification, safety assessment, functional studies and human clinical research, we continue to build its evidence base for infants and young children. Our research with APC, an important partner of Wecare, includes a clinical project involving BLa80 (𝐍𝐂𝐓𝟎𝟕𝟓𝟎𝟓𝟑𝟐𝟗), advancing its international clinical evidence. BLa80 has also been approved by China’s National Health Commission for use in infant and young children’s foods. I believe stronger strain-specific evidence is essential to the future of probiotics. We will continue to advance Wecare-developed strains from research to practical applications in wider markets. https://lnkd.in/grfC4qXK #probiotics #microbiome #LifeSciences #ClinicalResearch

How can probiotics support women’s health beyond weight management? Our latest article explores clinical findings on 𝐖𝐞𝐜𝐏𝐫𝐨®-𝐇𝐞𝐫𝐅𝐥𝐨𝐫𝐚, examining a three-strain blend’s effects on hormone metabolism, body composition and emotional wellbeing—and what these findings could mean for women’s health product development. Read the full article below for the science and formulation insights.👇

A meaningful milestone for Wecare Probiotics: construction has begun on our 600-tonne probiotic production project, and the expanded pilot platform at our intelligent manufacturing facility is now operational. Behind these milestones are years of dedication from our research and manufacturing teams. I believe the future of probiotics depends on both scientific discovery and the ability to bring it to scale. My thanks to everyone who has been part of this journey. We will keep pushing the boundaries of what probiotics can achieve. #probiotics #IntelligentManufacturing #StrainInnovation